Clinical Features of Cirrhotic Cardiomyopathy in Elderly Liver Transplant Recipients and Prognosis Analysis

Jian Li,Xueming Zhang,Ying Zheng,Zhiqing Qiao,Xuedong Shen,ZhangJianjun,Jieyan Shen

DOI: https://doi.org/10.3969/j.issn.1008-8296.2017.06.009

2017-01-01

Abstract:Objective To investigate the prevalence,clinical features and prognosis of cirrhotic cardiomyopathy (CCM) in elderly liver transplant recipients.Methods Elderly liver transplant recipients (≥60 years old) with no other known cardiac diseases,who had received orthotopic liver transplantation within the period from January,2012 to June,2015 in Renji Hospital,were included in this study;based on the results of echocardiography and ECG,diagnosis of CCM was made to cirrhotic patients with systolic or diastolic dysfunction while diagnosis of QTc interval prolongation was made to patients with QTc interval ＞440 ms;all the patients were followed up.Results A total of 63 elderly patients,aged at (64±9) years old,mostly male (75％),were included,27 patients (43％) with the diagnosis of CCM and 29 patients (46％) with the diagnosis of QTc interval prolongation;compared with patients with normal QTc interval,patients with QTc interval prolongation had higher Child-Pugh score (P=0.003),MELD score (P =0.008),serum bile acid (P=0.01),bilirubin (P=0.007) and INR (P=0.02) but a lower fibrinogen (P=0.04).MELD score was independently related to QTc length (R=0.32,R2=0.1,P=0.007);postoperative follow-up lasted for (24.7 ± 10.3) months;Compared with patients,Kaplan-Meier survival curve showed a lower survival rate in patients with prolonged QTc interval than in patients with normal QTc interval (P=0.047,HR2.69).Conclusions The prevalence of CCM and QTc interval prolongation in elderly liver transplant recipients was 43 ％ and 46％ respectively;patients with QTc interval prolongation have more serious liver disease and poorer prognosis.